"MK-677 (ibutamoren) not approved for any indication." FDA drug databases, accessed 2025
doi: 10.1111/j.1749-6632.2009.04799.x 95 ArnettSVAllevaLMKorossy-HorwoodRClarkIA
2024), BD Medical Technologies pen-needle product specifications, the FDA's guidance on single-use medical devices, and the 2022 Diabetes Technology and Therapeutics electron-microscopy study on reused pen-needle integrity (Strauss et al.)
Summary Keywords oxidative stress, child, kidney damage, systemic progression, nutritional management Citation Jechel E, Nedelcu AH, Dragan F, Lupu VV, Starcea IM, Mocanu A, Rosu ST, Streanga V, Russu R, Baciu G, Danielescu C, Salaru DL, Morariu ID, Cirstea O, Anton E and Lupu A (2025) Nutritional management of pediatric nephrotic syndrome regarding oxidative stress and antioxidant balance